Gitlab
GTLB
51.99
+0.36
+0.70%
Gitlab
US · GTLB
#1640 by market cap
Listed 2021
51.99
+0.36
+0.70%
Live - 5344 symbols - heartbeat 203s ago
· 2026-10-08 08:28
Pre-market
51.66
-0.63%
After-hours
51.99
0.00%
Overnight
51.98
-0.02%
- Market cap
- 8.66B
- P/E (TTM)i
- -162.47
- P/Bi
- 9.36
- EPSi
- -0.34
- Div yieldi
- 0.00%
- 52W posi
- 90%
Reader sentiment
Are you bullish or bearish on GTLB?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 7.69, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 7 years
Latest year +25.81% YoY
Margins
- Gross margin
- 87.36%
- Operating margin
- -7.38%
- Net margin
- -5.86%
Key ratios & quality
- Altman Z-Scorei
- 7.69
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | 81.23M | 152.18M | 252.65M | 424.34M | 579.91M | 759.25M | 955.22M |
| Gross profit | 71.85M | 133.71M | 222.67M | 372.66M | 520.20M | 674.11M | 834.48M |
| Selling & admin expenses | 140.85M | 240.95M | 254.41M | 427.92M | 506.80M | 577.17M | 630.39M |
| Research & development | 59.36M | 106.64M | 97.22M | 156.14M | 200.84M | 239.65M | 274.57M |
| Operating profit | -128.37M | -213.88M | -128.96M | -211.41M | -187.44M | -142.72M | -70.48M |
| Pretax profit | -129.54M | -189.36M | -159.07M | -175.29M | -160.57M | -85.79M | -48.07M |
| Tax | 1.20M | 2.83M | -1.51M | 4.03M | 265.15M | -76.67M | 10.50M |
| Net profit | -130.74M | -192.19M | -157.56M | -181.79M | -429.54M | -9.12M | -58.56M |
| Basic EPS | -1 | -1 | -2 | -1 | -3 | 0 | 0 |
| Diluted EPS | -0.99 | -1.45 | -1.95 | -1.17 | -2.76 | -0.04 | -0.34 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 214.51M | 235.96M | 244.35M | 260.40M | 264.16M | 286.25M |
| Gross profit | 189.47M | 207.46M | 212.13M | 225.42M | 226.67M | 240.62M |
| Selling & admin expenses | 158.67M | 154.32M | 155.77M | 161.62M | 170.94M | 202.57M |
| Research & development | 65.41M | 71.49M | 68.72M | 68.96M | 71.48M | 94.98M |
| Operating profit | -34.61M | -18.35M | -12.36M | -5.16M | -15.75M | -56.94M |
| Pretax profit | -33.72M | -7.75M | -6.99M | 391.00K | -3.55M | -39.33M |
| Tax | 2.54M | 2.25M | 1.81M | 3.90M | 2.03M | -3.20M |
| Net profit | -36.26M | -10.00M | -8.80M | -3.51M | -5.58M | -36.13M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.22 | -0.06 | -0.05 | -0.02 | -0.03 | -0.22 |
Balance sheet
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Total current assets | 384.48M | 348.49M | 1.05B | 1.12B | 1.28B | 1.34B | 1.66B |
| Cash & ST investments | 343.33M | 282.85M | 934.70M | 936.65M | 1.04B | 992.38M | 1.26B |
| Inventory | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 391.85M | 362.57M | 1.09B | 1.17B | 1.32B | 1.40B | 1.72B |
| Total current liabilities | 77.79M | 127.18M | 241.60M | 306.30M | 677.16M | 545.03M | 652.14M |
| Short-term debt | -- | -- | -- | 716.00K | 410.00K | 275.00K | 187.00K |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 526,595,000.00 | 593,788,000.00 | 292,169,000.00 | 344,475,000.00 | 715,011,000.00 | 577,957,000.00 | 686,499,000.00 |
| Total equity | -134.75M | -231.22M | 799.27M | 824.73M | 606.39M | 821.31M | 1.04B |
| Retained earnings | -206.01M | -398.20M | -553.34M | -725.65M | -1.16B | -1.17B | -1.22B |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 1.38B | 1.44B | 1.51B | 1.66B | 1.64B | 1.60B |
| Cash & ST investments | 1.10B | 1.17B | 1.20B | 1.26B | 1.36B | 1.26B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 1.44B | 1.50B | 1.57B | 1.72B | 1.71B | 1.66B |
| Total current liabilities | 556.38M | 553.36M | 565.81M | 652.14M | 643.05M | 662.31M |
| Short-term debt | -- | -- | -- | 187.00K | -- | -- |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 589,393,000.00 | 586,605,000.00 | 602,842,000.00 | 686,499,000.00 | 674,147,000.00 | 690,345,000.00 |
| Total equity | 852.60M | 911.58M | 968.00M | 1.04B | 1.03B | 971.49M |
| Retained earnings | -1.20B | -1.21B | -1.22B | -1.22B | -1.23B | -1.27B |
Cash flow
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -60.17M | -73.58M | -49.81M | -77.41M | 35.04M | -63.97M | 232.86M |
| Depreciation & amortization | 0 | 222.00K | 1.21M | 5.59M | 6.54M | 10.99M | 11.35M |
| Free cash flow | -60.17M | -73.58M | -53.36M | -83.48M | 33.44M | -67.74M | 222.03M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | -820.00K | 653.96M | -- | -- | -- | -- |
| Ending cash balance | 343.33M | 282.85M | 887.17M | 297.90M | 288.00M | 227.65M | 229.58M |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 106.30M | 49.37M | 31.43M | 45.76M | 149.20M | -3.09M |
| Depreciation & amortization | 2.58M | 2.77M | 2.88M | 3.11M | 3.31M | 3.36M |
| Free cash flow | 105.39M | 46.47M | 28.39M | 41.78M | 146.80M | -3.31M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | -- | -- | -50.05M | -104.64M |
| Ending cash balance | 255.72M | 261.37M | 224.23M | 229.58M | 335.40M | 226.49M |
Returns & efficiency
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -57.07 | -22.29 | -63.21 | -0.94 | -6.34 |
| ROA %i | -33.37 | -50.95 | -21.34 | -15.24 | -34.11 | -0.47 | -3.58 |
| ROIC %i | -- | -- | -57.34 | -23.74 | -67.73 | -6.53 | -9.44 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -30.15 |
| EBIT margin %i | -158.03 | -140.55 | -51.04 | -49.82 | -32.32 | -18.80 | -7.38 |
| FCF / sales %i | -- | -- | -- | -- | 5.77 | -- | 23.24 |
| Current ratioi | 4.94 | 2.74 | 4.35 | 3.65 | 1.90 | 2.45 | 2.54 |
| Quick ratioi | 4.74 | 2.54 | 4.19 | 3.50 | 1.79 | 2.33 | 2.42 |
| Debt / assetsi | -- | -- | 0.00 | 0.10 | 0.03 | 0.02 | 0.01 |
| LT debt / equityi | -- | -- | -- | 0.05 | -- | -- | -- |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | 73.51 | 56.20 | 44.31 | 31.06 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 1.89 | -1.20 | -5.64 | -6.34 | -2.79 | -5.88 |
| ROA %i | 0.94 | -0.63 | -3.29 | -3.58 | -1.59 | -3.33 |
| ROIC %i | -3.45 | -5.94 | -10.55 | -9.44 | -5.92 | -9.06 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -15.37 | -11.78 | -9.34 | -7.38 | -5.14 | -8.55 |
| FCF / sales %i | 0.03 | 4.18 | 26.74 | 23.24 | 26.22 | 20.25 |
| Current ratioi | 2.48 | 2.60 | 2.66 | 2.54 | 2.55 | 2.41 |
| Quick ratioi | 2.35 | 2.46 | 2.52 | 2.42 | 2.42 | 2.29 |
| Debt / assetsi | -- | -- | -- | 0.01 | -- | -- |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 08:28:41 · For reference only, not investment advice and not tailored to your situation.